https://www.macrotrends.net/stocks/charts/ATYR/atyr-pharma/eps-earnings-per-share-diluted
ATyr Pharma eps - earnings per share from 2014 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common...
earnings per shareatyr pharmaepsmacrotrends
https://www.ainvest.com/stocks/NASDAQ-ATYR/community/
Track the live stock price of ATYR, get real-time quotes, and access in-depth analysis and prediction. Stay ahead of the market with AInvest's AI-powered tools.
atyr pharmaprice quoteforecastget
https://www.macrotrends.net/stocks/charts/ATYR/atyr-pharma/quick-ratio
Historical quick ratio values for ATyr Pharma (ATYR) over the last 10 years.
atyr pharmaquick ratiomacrotrends
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-cf-pharmatech-aurealis-pharma-atyr-pharma-5913385/
CF PharmaTech has secured $65m in a series D financing round led by SDIC. The Chinese respiratory drug developer plans to use the funds for the development of...
dealsweekcfpharmatechaurealis
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-atyr/atyr-pharma/news/atyr-pharma-incs-nasdaqatyr-path-to-profitability
We feel now is a pretty good time to analyse aTyr Pharma, Inc.'s ( NASDAQ:ATYR ) business as it appears the company may...
atyr pharmaincnasdaqpathprofitability
https://www.pharmaceutical-technology.com/news/deals-this-week-medicines-for-malaria-venture-swedish-orphan-biovitrum-atyr-pharma/
Medicines for Malaria Venture (MMV) has entered a collaboration with Drugs for Neglected Disease initiative (DNDi) to create a pandemic response box.
swedish orphan biovitrumdealsweekmedicinesmalaria